• Home
  • Search
  • Browse Collections
  • My Account
  • About
  • DC Network Digital Commons Network™
Skip to main content
Jefferson University logo Jefferson Libraries Home Academic Commons Home Search
  • Home
  • About
  • Submit Research
  • My Account
Jefferson Digital Commons

Home > SKMC > OMS > OMSPOSTERS

Department of Oral and Maxillofacial Surgery Posters

 
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.

Follow

Switch View View Slideshow
 
  • Reconstruction of Marginal Mandibular Defects Utilizing Bone Marrow Aspirate Concentrate (BMAC) from the Anterior Iliac Crest: A Less Morbid Osteogenic Option by Shachika Khanna, BDS, DMD; Rafael Gavilanes, DMD; Robert Diecidue, DMD, MD, MBA, MSPH; Daniel Taub, DDS, MD; and Alyssa Flashburg, DMD

    Reconstruction of Marginal Mandibular Defects Utilizing Bone Marrow Aspirate Concentrate (BMAC) from the Anterior Iliac Crest: A Less Morbid Osteogenic Option

    Shachika Khanna, BDS, DMD; Rafael Gavilanes, DMD; Robert Diecidue, DMD, MD, MBA, MSPH; Daniel Taub, DDS, MD; and Alyssa Flashburg, DMD

    The aim of this case series, is to describe our surgical technique for reconstructing benign mandibular neoplasms using BMAC – a less invasive approach than traditional iliac crest bone graft harvest.

    BMAC was used in combination with mineralized freeze-dried allograft, platelet rich plasma (PRP) & bone morphogenic protein (rhBMP-2) to reconstruct the hard tissue lost secondary to the ablative tumor resection.

    • 10 patients included in the retrospective case series were treated between 2014 and 2017 by 3 surgeons.
    • Mean age - 44 years (range - 19 to 77 years). BMAC was obtained from the anterior iliac crest (AIC).
    • When appropriate, a custom milled mandibular reconstruction plate was placed.
    • Maxillofacial pathology included benign neoplasms such as Ameloblastoma, Cavernous Hemangioma, Central Giant Cell Granuloma (CGCG), Dentigerous Cyst & Keratocystic Odontogenic Tumor (KOT).

  • Treatment of Obstructive Sleep Apnea with Maxillo-mandibular Advancement Surgery: Evaluation and Predictors of Success by Daniel Taub, DMD, MD; Michael Courtney, DMD, MD; and Karl Doghramji, MD

    Treatment of Obstructive Sleep Apnea with Maxillo-mandibular Advancement Surgery: Evaluation and Predictors of Success

    Daniel Taub, DMD, MD; Michael Courtney, DMD, MD; and Karl Doghramji, MD

    Obstructive sleep apnea (OSA) is a well-recognized disease entity affecting approximately 2% to 4% of the population. Maxillomandibular advancement (MMA) surgery is a highly successful surgical alternative to poorly tolerated CPAP therapy and achieves a success rate of 89% in the current literature. Our present study evaluates the effectiveness of MMA surgery in the treatment of patients with moderate to severe OSA based on Shers criteria of 50% reduction in AHI and AHI < 20. Radiographic and clinical treatment variables were evaluated in determining predictors of success for MMA in individuals with OSA.

 
 
 

Browse

  • Collections
  • Authors
  • Disciplines

Search

Advanced Search

  • Notify me via email or RSS

Author Corner

  • Copyright & Fair Use
  • What is Open Access?
  • Open Access Publishing Fund

About the JDC

  • What People Are Saying About the JDC
  • Frequently Asked Questions

Links

  • JDC Release Form
  • Feedback Form
  • Twitter
  • Instagram
 
Digital Commons

Home | About | FAQ | My Account | Accessibility Statement

Privacy Copyright